Synthesis and characterization of a new mebendazole salt: mebendazole hydrochloride.

Mebendazole hydrochloride [(5-benzoyl-1H-benzimidazole-2-yl)-carbamic acid methyl ester hydrochloride, MBZ.HCl], a new stable salt of mebendazole (MBZ), has been synthesized and characterized. It can easily be obtained from recrystallization of forms A, B, or C of MBZ in diverse solvents with the addition of hydrochloric acid solution. Crystallographic data reveals that the particular conformation adopted by the carbamic group contributes to the stability of the network. The crystal packing is stabilized by the presence of three N-H...Cl intermolecular interactions that form chains along the b axis. The XRD analyses of the three crystalline habits found in the crystallization process (square-based pyramids, pseudohexagonal plates, and prismatic) show equivalent diffraction patterns. The vibrational behavior is consistent with crystal structure. The most important functional groups show shifts to lower or higher frequencies in relation to the MBZ polymorphs. The thermal study on MBZ.HCl indicates that the compound is stable up to 160 degrees C approximately. Decomposition occurs in four steps. In the first step the HCl group is eliminated, and after that the remaining MBZ polymorph A decomposes in three steps, as happens with polymorphs B and C. (

[1]  M. D. de Villiers,et al.  Variable-temperature X-ray powder diffraction analysis of the crystal transformation of the pharmaceutically preferred polymorph C of mebendazole. , 2005, Journal of pharmaceutical and biomedical analysis.

[2]  M. D. de Villiers,et al.  Quality evaluation of generic drugs by dissolution test: changing the USP dissolution medium to distinguish between active and non-active mebendazole polymorphs. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[3]  M. D. de Villiers,et al.  Developing a discriminating dissolution test for three mebendazole polymorphs based on solubility differences. , 2003, Die Pharmazie.

[4]  M. Morsy,et al.  Normal Vibrational Mode Analysis and Assignment of Benzimidazole by ab Initio and Density Functional Calculations and Polarized Infrared and Raman Spectroscopy , 2002 .

[5]  M. Dhansay,et al.  Anthelmintic efficacy of mebendazole depends on the molecular polymorph. , 1999, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[6]  Louis J. Farrugia,et al.  WinGX suite for small-molecule single-crystal crystallography , 1999 .

[7]  T. Klots,et al.  Heteroatom derivatives of indene: V. Vibrational spectra of benzimidazole , 1997 .

[8]  Louis J. Farrugia,et al.  ORTEP-3 for Windows - a version of ORTEP-III with a Graphical User Interface (GUI) , 1997 .

[9]  J. Waikagul,et al.  Efficacy of single-dose mebendazole, polymorphic forms A and C, in the treatment of hookworm and Trichuris infections. , 1993, The Southeast Asian journal of tropical medicine and public health.

[10]  H. Aboul‐Enein,et al.  Analysis of mebendazole polymorphs by Fourier transform IR spectrometry using chemometric methods. , 2002, Biopolymers.

[11]  M. Caira,et al.  Structure of a 1:1 complex between the anthelmintic drug mebendazole and propionic acid , 1998 .

[12]  Robert M. Sweet,et al.  Macromolecular Crystallography: Part A , 1997 .

[13]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[14]  Olga Kennard,et al.  Tables of bond lengths determined by X-ray and neutron diffraction. Part 1. Bond lengths in organic compounds , 1987 .

[15]  F. Rodríguez-Caabeiro,et al.  Experimental chemotherapy and toxicity in mice of three mebendazole polymorphic forms. , 1987, Chemotherapy.